Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer

SIMPLE SUMMARY: Most patients with advanced non-small cell lung cancer (NSCLC) do not respond to programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis blockade, highlighting the need for the identification of new targets for immune checkpoint inhibition. In this study, we use...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Vathiotis, Ioannis A., MacNeil, Tyler, Zugazagoitia, Jon, Syrigos, Konstantinos N., Aung, Thazin Nwe, Gruver, Aaron M., Vaillancourt, Peter, Hughes, Ina, Hinton, Steve, Driscoll, Kyla, Rimm, David L.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957629/
https://ncbi.nlm.nih.gov/pubmed/33804482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051024
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki